Loading
Latest filing published 18 Dec 2020 for CASI Pharmaceuticals, Inc., €4,015.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Weihao Xu discloses dealings in CASI Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 16 December 2020 to 17 December 2020, the count stands at 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €13k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Half of the purchases are above €4,015 and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 18 December 2020, the filings show an open-market purchase worth €4,015 in CASI Pharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations